Three-year continuation of reversible contraception

American Journal of Obstetrics and Gynecology

Volumn 213, Issue 5, 2015, Pages 662.e1-662.e8

  Diedrich, Justin T ^a   Zhao, Qiuhong ^a   Madden, Tessa ^a   Secura, Gina M ^a   Peipert, Jeffrey F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

continuation; contraception; intrauterine device; long acting reversible contraception; subdermal implant

Indexed keywords

MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; CONTRACEPTIVE AGENT; LEVONORGESTREL;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; COHORT ANALYSIS; CONTRACEPTION; CONTRACEPTIVE PATCH; COPPER INTRAUTERINE DEVICE; DERMAL IMPLANT; DRUG WITHDRAWAL; FEMALE; HAZARD RATIO; HUMAN; INTERMETHOD COMPARISON; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; LONG ACTING REVERSIBLE CONTRACEPTION; MEDICAL DEVICE COMPLICATION; MUSCLE CRAMP; ORAL CONTRACEPTION; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; TELEPHONE INTERVIEW; VAGINA RING; COMPARATIVE STUDY; INTRAUTERINE CONTRACEPTIVE DEVICE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; INTRAUTERINE DEVICES, COPPER; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; YOUNG ADULT;

EID: 84946037814     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.08.001     Document Type: Article

References (21)

1. B. Winner, J.F. Peipert, Q. Zhao, and et al. Effectiveness of long-acting reversible contraception N Engl J Med 366 2012 1998 2007
2. Daniels K, Daugherty J, Jones J. Current contraceptive status among women aged 15 -44: United States, 2011 -2013. NCHS data brief, no 173. Hyattsville, MD: National Center for Health Statistics. 2014.
3. A. Branum, and J. Jones Trends in long-acting reversible contracepiton use among U.S. women aged 15-44 NCHS Data Brief 188 2015 1 8
4. M. O'Neil-Callahan, J.F. Peipert, Q. Zhao, T. Madden, and G. Secura Twenty-four-month continuation of reversible contraception Obstet Gynecol 122 2013 1083 1091
5. J.F. Peipert, Q. Zhao, J.E. Allsworth, and et al. Continuation and satisfaction of reversible contraception Obstet Gynecol 117 2011 1105 1113
6. I. Sivin, F. Alvarez, J. Diaz, and et al. Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices Contraception 30 1984 443 456
7. K. Andersson, V. Odlind, and G. Rybo Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial Contraception 49 1994 56 72
8. I. Sivin, S. el Mahgoub, T. McCarthy, and et al. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study Contraception 42 1990 361 378
9. UNDP/UNFPA/WHO/World Bank IRG A randomized multicentre trial of the Multiload 375 and TCu380A IUDs in parous women: three-year results. UNDP/UNFPA/WHO/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction: IUD Research Group Contraception 49 1994 543 549
10. C.B. Champion, B. Behlilovic, J.M. Arosemena, L. Randic, L.P. Cole, and L.R. Wilkens A three-year evaluation of TCu 380 Ag and multiload Cu 375 intrauterine devices Contraception 38 1988 631 639
11. E. Baldaszti, B. Wimmer-Puchinger, and K. Löschke Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study Contraception 67 2003 87 91
12. E. Weisberg, D. Bateson, K. McGeechan, and L. Mohapatra A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system Eur J Contracept Reprod Health Care 19 2014 5 14
13. F. Lakha, and A.F. Glasier Continuation rates of Implanon in the UK: data from an observational study in a clinical setting Contraception 74 2006 287 289
14. K. Rai, S. Gupta, and S. Cotter Experience with Implanon in a north-east London family planning clinic Eur J Contracept Reprod Heal Care 9 2004 39 46
15. A. Agrawal, and C. Robinson An assessment of the first 3 years' use of Implanon in Luton J Fam Plan Reprod Health Care 31 2005 310 312
16. G.M. Secura, J.E. Allsworth, T. Madden, J.L. Mullersman, and J.F. Peipert The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception Am J Obstet Gynecol 203 2010 115.e1 115.e7
17. T. Madden, J.L. Mullersman, K.J. Omvig, G.M. Secura, and J.F. Peipert Structured contraceptive counseling provided by the Contraceptive CHOICE Project Contraception 88 2013 243 249
18. J.R. Rosenstock, J.F. Peipert, T. Madden, Q. Zhao, and G.M. Secura Continuation of reversible contraception in teenagers and young women Obstet Gynecol 120 2012 1298 1305
19. G.M. Secura, and C. McNicholas Long-acting reversible contraceptive use among teens prevents unintended pregnancy: a look at the evidence Expert Rev Obstet Gynecol 8 2013 297 299
20. C. McNicholas, R. Maddipati, Q. Zhao, E. Swor, and J.F. Peipert Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration Obstet Gynecol 125 2015 599 604
21. G.M. Secura, T. Madden, C. McNicholas, and et al. Provision of no-cost, long-acting contraception and teenage pregnancy N Engl J Med 371 2014 1316 1323